2-185738694-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NR_110217.1(FSIP2-AS2):n.99+1685G>A variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,383,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
FSIP2-AS2
NR_110217.1 intron, non_coding_transcript
NR_110217.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.282
Genes affected
FSIP2-AS2 (HGNC:54061): (FSIP2 antisense RNA 2)
FSIP2-AS1 (HGNC:40978): (FSIP2 antisense RNA 1)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | NR_110217.1 | n.99+1685G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | ENST00000421998.5 | n.28G>A | non_coding_transcript_exon_variant | 1/4 | 1 | |||||
FSIP2-AS2 | ENST00000427269.2 | n.101+1685G>A | intron_variant, non_coding_transcript_variant | 5 | ||||||
FSIP2-AS1 | ENST00000667756.1 | n.37+50072G>A | intron_variant, non_coding_transcript_variant | |||||||
FSIP2-AS2 | ENST00000437717.1 | n.119+213G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000688 AC: 9AN: 130740Hom.: 0 AF XY: 0.0000562 AC XY: 4AN XY: 71206
GnomAD3 exomes
AF:
AC:
9
AN:
130740
Hom.:
AF XY:
AC XY:
4
AN XY:
71206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000108 AC: 15AN: 1383730Hom.: 0 Cov.: 31 AF XY: 0.0000103 AC XY: 7AN XY: 682818
GnomAD4 exome
AF:
AC:
15
AN:
1383730
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
682818
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.67C>T (p.L23F) alteration is located in exon 1 (coding exon 1) of the FSIP2 gene. This alteration results from a C to T substitution at nucleotide position 67, causing the leucine (L) at amino acid position 23 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at